Abstract
BackgroundColorectal cancer (CRC) is the second cause of tumour mortality in Spain and Europe. To date, no studies have been conducted in Spain to evaluate the spatial and temporal distribution of the excess risk of death during hospitalisation for CRC.MethodsA cohort was constructed of all episodes of hospitalisation in Spain due to CRC (codes 153 and 154 of the International Classification of Diseases, 9th edition, Clinical Modification) during the period 2008–2014, based on the minimum basic data set published by the Ministry of Health. Mortality ratios were calculated per region for each of the years analyzed (spatial or cross-sectional analysis) and during the overall study period, for each region independently (temporal or longitudinal analysis). In the first of these analyses, particular note was taken of the regions and years in which the limits of two and three standard deviations were exceeded.ResultsTwo hundred and fifty eight thousand, nine hundred and twenty seven episodes of CRC were analysed. The patients were predominantly male (60.6%), with an average hospital stay of 13.16 days. Half underwent surgery during admission and on average presented more than six diagnoses at discharge. The spatial analysis revealed mortality ratios that deviated by at least three standard deviations in the following regions: Islas Canarias, Asturias, Valencia, Extremadura, País Vasco and Andalucía. The longitudinal analysis showed that most regions presented one or more years when CRC mortality was at least 15% higher than expected during the period; outstanding in this respect were Asturias, Navarra and La Rioja, where this excess risk was detected in at least 2 years.ConclusionsGeographic and temporal patterns of the distribution of the excess risk of mortality from CRC in Spain are described using SMRs. We conclude that during the study period, the geographic pattern of mortality in Spain did not coincide with the excess risk of mortality calculated using the SMR method described by Jarman and Foster. This method of risk estimation can be a useful tool for the study of mortality risk and its spatial variations.
Highlights
Colorectal cancer (CRC) is the second cause of tumour mortality in Spain and Europe
Case-mix regarding the cases studied In line with previous research in Spain and elsewhere in Europe [11, 30,31,32], our results show that mortality from CRC is higher in male than in female patients, in all regions
Comparison of the findings reported by Etxeberría et al for the period 1975–2008 [30], for the geographic distribution of CRC mortality, with our own results shows that the respective study periods overlap, with our research focusing on more recent years
Summary
Colorectal cancer (CRC) is the second cause of tumour mortality in Spain and Europe. To date, no studies have been conducted in Spain to evaluate the spatial and temporal distribution of the excess risk of death during hospitalisation for CRC. CRC is the second most common cancer in women, after breast cancer, and in men, after prostate cancer Among both sexes, it is the third most common cancer worldwide [2], and the second cause of cancer mortality in Europe [3,4,5,6]. In the last 20 years, the mortality due to CRC has declined significantly in northern and western Europe, while it has increased in most countries in southern, central and eastern Europe [4]. In this context, Spain is among the middle-ranking countries in Europe. Epidemiological studies in Spain reflect a gradual increase in mortality in recent years [8,9,10], as well as in incidence, probably because the disease is being detected at an increasingly early stage, with the use of new diagnostic techniques [11]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.